GGrantIndex
← Leaderboards

Susan M Fischer

University Of Texas Md Anderson Can Ctr

Google Scholar ↗PubMed ↗ORCID ↗
$12,916,650
Attributed
$12,916,650
Total exposure
11
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY2005–12
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$12,916,650 · 11

By mechanism

R01$7,986,443 · 6
U01$4,151,680 · 1
P30$454,812 · 1
R21$307,715 · 1
R13$16,000 · 2

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Skin Neoplasms”

Research focus

Skin NeoplasmsInflammationLaboratory MouseIncidenceCyclooxygenase 2ProstaglandinsPathway InteractionsMalignant NeoplasmsChemopreventionSkinPancreatic AdenocarcinomaKeratin 5LinkMalignant Neoplasm Of PancreasChronic PancreatitisInhibitor/AntagonistTumorInfiltrationHuman DiseaseKeratinocyteSignal PathwayPhenotypeSignal TransductionUltraviolet Radiation

Grant awards (40)

Obesity and Pancreatic Cancer: The Role of IGF-1$319,809
R01 · FY2012 · CA · contact PI
Cyclooxygenase-2 Induced Pancreatic Cancer$309,964
R01 · FY2012 · CA · contact PI
Obesity and Pancreatic Cancer: The Role of IGF-1$329,402
R01 · FY2011 · CA · contact PI
Cyclooxygenase-2 Induced Pancreatic Cancer$309,964
R01 · FY2011 · CA · contact PI
Obesity and Pancreatic Cancer: The Role of IGF-1$349,773
R01 · FY2010 · CA · contact PI
Cyclooxygenase-2 Induced Pancreatic Cancer$319,550
R01 · FY2010 · CA · contact PI
Obesity and Pancreatic Cancer: The Role of IGF-1$343,390
R01 · FY2009 · CA · contact PI
Cyclooxygenase-2 Induced Pancreatic Cancer$319,550
R01 · FY2009 · CA · contact PI
Mouse Models of Skin Cancer$828,552
U01 · FY2008 · CA · contact PI
Cyclooxygenase-2 Induced Pancreatic Cancer$319,550
R01 · FY2008 · CA · contact PI
Prevention of Prostate Carcinogenesis in Transgenic Mice$287,059
R01 · FY2008 · CA · contact PI
Mouse Models of Skin Cancer$823,278
U01 · FY2007 · CA · contact PI
COX-2 in Skin Carcinogenesis$318,565
R01 · FY2007 · CA · contact PI
Prevention of Prostate Carcinogenesis in Transgenic Mice$287,059
R01 · FY2007 · CA · contact PI
COX-2 Driven Pancreatic Adenocarcinoma$193,715
R21 · FY2007 · CA · contact PI
Mouse Models of Skin Cancer$826,068
U01 · FY2006 · CA · contact PI
COX-2 in Skin Carcinogenesis$328,079
R01 · FY2006 · CA · contact PI
Prevention of Prostate Carcinogenesis in Transgenic Mice$295,632
R01 · FY2006 · CA · contact PI
COX-2 Driven Pancreatic Adenocarcinoma$114,000
R21 · FY2006 · CA · contact PI
VII International Skin Carcinogenesis Conference (ISCC)$10,000
R13 · FY2006 · CA · contact PI
Mouse Models of Skin Cancer$823,782
U01 · FY2005 · CA
COX-2 in Skin Carcinogenesis$335,975
R01 · FY2005 · CA
Prevention of Prostate Carcinogenesis in Transgenic Mice$302,748
R01 · FY2005 · CA
Mouse Models of Skin Cancer$850,000
U01 · FY2004 · CA
8 LOX AND SKIN CANCER SUSCEPTIBILITY$351,954
R01 · FY2004 · CA
COX-2 in Skin Carcinogenesis$335,975
R01 · FY2004 · CA
Prevention of Prostate Carcinogenesis in Transgenic Mice$302,748
R01 · FY2004 · CA
6th International Skin Carcinogenesis Conference$6,000
R13 · FY2004 · CA
8 LOX AND SKIN CANCER SUSCEPTIBILITY$349,568
R01 · FY2003 · CA
COX-2 in Skin Carcinogenesis$335,975
R01 · FY2003 · CA
8 LOX AND SKIN CANCER SUSCEPTIBILITY$347,250
R01 · FY2002 · CA
CORE--MECHANISMS OF DISEASE PREVENTION$73,467
P30 · FY2002 · ES
8 LOX AND SKIN CANCER SUSCEPTIBILITY$269,325
R01 · FY2001 · CA
CORE--MECHANISMS OF DISEASE PREVENTION$117,873
P30 · FY2001 · ES
CORE--MECHANISMS OF DISEASE PREVENTION$73,467
P30 · FY2001 · ES
8 LOX AND SKIN CANCER SUSCEPTIBILITY$56,250
R01 · FY2001 · CA
ARACHIDONATE METABOLITES AND TUMOR PROMOTION$291,779
R01 · FY2000 · CA
8 LOX AND SKIN CANCER SUSCEPTIBILITY$269,550
R01 · FY2000 · CA
CORE--NUTRITION AND DISEASE PREVENTION$117,873
P30 · FY2000 · ES
CORE--NUTRITION AND DISEASE PREVENTION$72,132
P30 · FY2000 · ES